Life sciences industry outlook, Spring 2021

May 10, 2021

From expanding digital health opportunities to increased scrutiny on mergers, life sciences companies face a variety of issues.

Posted by RSM

KEY TAKEAWAYS FROM THE SPRING 2021 LIFE SCIENCES INDUSTRY OUTLOOK

  • As the pandemic evolves to become an endemic part of life, life sciences companies, along with other businesses, must consider new technologies, business models and consumer preferences.
  • Strong capital markets continue to propel growth in the industry, while public markets reflect long-term growth opportunities.
  • The Federal Trade Commission has voiced a more skeptical tone toward life sciences mergers.
  • Over the last several months, the pharmaceutical industry has seen an improvement in public perception

Read the complete Life Sciences Industry Outlook report here

 

See all Member News